DK0773030T3 - Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella - Google Patents

Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella

Info

Publication number
DK0773030T3
DK0773030T3 DK95921113T DK95921113T DK0773030T3 DK 0773030 T3 DK0773030 T3 DK 0773030T3 DK 95921113 T DK95921113 T DK 95921113T DK 95921113 T DK95921113 T DK 95921113T DK 0773030 T3 DK0773030 T3 DK 0773030T3
Authority
DK
Denmark
Prior art keywords
toxoid
dermonecrotic toxin
produced
bordetella
dermonecrotic
Prior art date
Application number
DK95921113T
Other languages
Danish (da)
English (en)
Inventor
Toru Kawai
Toshihiro Ushijima
Kozo Takase
Hideo Fujikawa
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK0773030T3 publication Critical patent/DK0773030T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95921113T 1994-06-10 1995-06-07 Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella DK0773030T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15283494 1994-06-10
PCT/JP1995/001125 WO1995034322A1 (fr) 1994-06-10 1995-06-07 Procede d'epuration d'une necrotoxine produite par bordetella, et anatoxine d'une telle necrotoxine

Publications (1)

Publication Number Publication Date
DK0773030T3 true DK0773030T3 (da) 2003-12-22

Family

ID=15549157

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95921113T DK0773030T3 (da) 1994-06-10 1995-06-07 Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella
DK02028045T DK1297845T3 (da) 1994-06-10 1995-06-07 Kombinationsvaccine omfattende toxoid af dermonekrotisk toxin produceret af Bordetella bronchiseptica

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02028045T DK1297845T3 (da) 1994-06-10 1995-06-07 Kombinationsvaccine omfattende toxoid af dermonekrotisk toxin produceret af Bordetella bronchiseptica

Country Status (10)

Country Link
US (1) US6124432A (zh)
EP (2) EP0773030B8 (zh)
JP (2) JP3884066B2 (zh)
CN (2) CN1279978C (zh)
AT (2) ATE248603T1 (zh)
CA (1) CA2192165A1 (zh)
DE (2) DE69535964D1 (zh)
DK (2) DK0773030T3 (zh)
ES (2) ES2326793T3 (zh)
WO (1) WO1995034322A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine
CN103153337A (zh) 2010-09-28 2013-06-12 共立制药股份有限公司 黏膜佐剂组合物
IT201600076743A1 (it) * 2016-07-21 2018-01-21 St Superiore Di Sanita Nuovo uso del cnf1
CN107338208B (zh) * 2017-08-17 2020-07-28 天康生物股份有限公司 一种猪萎缩性鼻炎d型产毒多杀巴斯德氏菌疫苗株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
EP0651609B1 (en) * 1990-06-13 1999-08-11 Pfizer Inc. Pasteurella multocida toxoid vaccines

Also Published As

Publication number Publication date
CN1130225C (zh) 2003-12-10
EP0773030A4 (en) 1997-12-10
CN1154655A (zh) 1997-07-16
CN1279978C (zh) 2006-10-18
JP4340672B2 (ja) 2009-10-07
DK1297845T3 (da) 2009-07-13
EP1297845A3 (en) 2003-04-16
EP1297845A2 (en) 2003-04-02
ES2326793T3 (es) 2009-10-20
ATE432712T1 (de) 2009-06-15
US6124432A (en) 2000-09-26
ES2206507T3 (es) 2004-05-16
WO1995034322A1 (fr) 1995-12-21
EP0773030A1 (en) 1997-05-14
CN1494922A (zh) 2004-05-12
EP1297845B1 (en) 2009-06-03
JP2006342175A (ja) 2006-12-21
CA2192165A1 (en) 1995-12-21
DE69531690D1 (de) 2003-10-09
ATE248603T1 (de) 2003-09-15
JP3884066B2 (ja) 2007-02-21
DE69535964D1 (de) 2009-07-16
EP0773030B1 (en) 2003-09-03
EP0773030B8 (en) 2004-01-14
DE69531690T2 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
ATE249244T1 (de) Aktivierte verbindungen und verfahren zur herstellung und reiningung
ATE44238T1 (de) Vakzine fuer gramnegative bakterien und verfahren zur herstellung derselben.
DK530587D0 (da) Fremgangsmaade til oprensning af toxinkonjugater
HUP0002475A2 (hu) Módosított immunogén pneumolizinkészítmények mint vakcinák
ATE69310T1 (de) Verfahren zur herstellung eines materials zur affinitaetschromatographie.
NZ215557A (en) Purification of immunoglobulin g using liquid chromatography or solid phase extraction
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DK0773030T3 (da) Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella
ES2105033T3 (es) Metodo de purificacion de proteinas.
FI101380B1 (fi) Menetelmä 69 000 daltonin antigeeniproteiinin puhdistamiseksi Bordetella pertussis -bakteerista
ATE2090T1 (de) Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel.
FI952144A0 (fi) Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle
PT816377E (pt) Peptideos que se ligam a protrombina e a trombina
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
DE3875296D1 (de) Verfahren zur selektiven n-acylierung von amino-hydroxamsaeurederivaten und darin verwendete ausgangsstoffe.
GB2007244A (en) Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
DK0408734T3 (da) Fremgangsmåde til rensning af streptokinaser
JPS57140726A (en) Purification of physiologically active substance having carcinostatic action
AU603794B2 (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
FR2104732A1 (en) Asparaginase purification using asparagine in - hibitors coupled to carbohydrate matrix
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.
FI935161A (fi) Menetelmä plasmaproteiinien TTR ja RBP eristämiseksi ja jatkopuhdistamiseksi
SU1564788A1 (ru) Способ получения стафилококкового энтеротоксина типа а